Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Chronic Hepatitis Delta: early-phase trial registry

1 of 1 indexed Chronic Hepatitis Delta trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Chronic Hepatitis Delta: 1 US clinical trial tracked, 1 recruiting.

Chronic Hepatitis Delta is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Gilead Sciences, running 1 of these trials.

Enrollment posture brief

Registry condition chronic-hepatitis-delta

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Chronic Hepatitis Delta (thi…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Chronic Hepatitis Delta

Chronic Hepatitis Delta lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Hepatitis Delta on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Hepatitis Delta is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Gilead Sciences 1 trials

Named interventions

Most-linked intervention names on Chronic Hepatitis Delta records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

GS-4321 Placebo Drug
1 trials
GS-4321 Drug
1 trials

US sites by state

Facility locations filed on Chronic Hepatitis Delta trials. A trial with sites in several states counts in each.

California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Hepatitis Delta page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Chronic Hepatitis Delta trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Gilead Sciences sponsors the most Chronic Hepatitis Delta trials on record, review their full trial history before evaluating a specific study. See Gilead Sciences's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Hepatitis Delta condition card totals 1 registered trials; most-linked intervention GS-4321 Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.